strategies to target innate immunity in cancer therapy have epkrged, including therapeutic stimulation of pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs); the DNA sensing cGAS/STING pathway; nucleotide-binding oligopkrization domain-like receptors (NLRs)